Photo of Dr Marco Siccardi

Dr Marco Siccardi PhD

Reader Pharmacology & Therapeutics

Research

Research Interest 1


Research Group Membership

Research Grants

Safety Testing In The Life Cycle Of Nanotechnology-Enabled Medical Technologies For Health

EUROPEAN COMMISSION

April 2019 - March 2023

Microneedle patches for antiretroviral delivery

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

August 2019 - July 2022

VIrTUAL - Vulnerable populatIon TUberculosis AntiretroviraL

EDCTP (NETHERLANDS)

February 2018 - January 2023

Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices (REFINE)

EUROPEAN COMMISSION

December 2017 - February 2022

Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

July 2015 - June 2021

Antiretroviral therapy (ART) simplification

WITS REPRODUCTIVE HEALTH & HIV INSTITUTE (S AFRICA)

October 2015 - October 2020

Computational models for the prediction of PK in special populations

UNIVERSITY HOSPITAL BASEL (SWITZERLAND)

January 2017 - January 2020

Pharmacologic strategies to use the levonorgestrel implant in HIV-infected women

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

December 2015 - November 2020

Long acting NRTI therapies for HIV

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

July 2017 - June 2021

Antiretroviral pharmacogenetics

ZARQA UNIVERSITY (JORDAN)

November 2014 - October 2017

Towards complete sustained release nanoformulations of NRTI based regimens

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

July 2014 - June 2019

Integrated radiomaterials chemistry for simultaneous multi-component tracking of nanomedicines in biological matrices

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

September 2014 - March 2018

Population pharmacokinetic-pharmacodynamic (PKPD) optimization of new toxicity biomarkers

TAIF UNIVERSITY (SAUDI ARABIA)

November 2014 - October 2017

Effectiveness of Antiretroviral Therapy in Nigeria

NATIONAL UNIVERSITIES COMMISSION (NIGERIA)

November 2014 - October 2017

Development of solid drug nanoparticle for treatment of mycobacterium tuberculosis

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

October 2013 - December 2013